Acute asthma (severe/life-threatening) (Formulary)

MAGNESIUM SULFATE

Important: Therapy notes

  • MHRA advice: Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy (May 2019) (www.gov.uk)

Important: Formulation and dosage details

Formulation:

Injection 50% 1 gram/2mL (Restricted: Hospital use only) 

Dosage:

For severe asthma off-label, following consultation with senior medical staff. Magnesium sulfate 1·2 to 2 grams may be given by intravenous infusion over 20 minutes.

Guidance:

Editorial Information

Document Id: F368